Ulipristal CAS 126784-99-4

Iden­ti­fi­ca­tion Prop­er­ties Safe­ty Data Spec­i­fi­ca­tions and Oth­er Information Links

Iden­ti­fi­ca­tion

CAS Number

126784-99-4

Name

Ulipristal

Syn­onyms

(11β)-11-[4-(Dimethylamino)phenyl]-3,20-dioxo-19-norpregna-4,9-dien-17-yl acetate [ACD/IUPAC Name] (11β)-11-[4-(Dimethylamino)phenyl]-3,20-dioxo-19-norpregna-4,9-dien-17-yl-acetat [Ger­man] [ACD/IUPAC Name] (11β)-17-(Acetyloxy)-11-(4-(dimethylamino)phenyl)-19-norpregna-4,9-diene-3,20-dione 126784-99-4 [RN] 19-Norpregna-4,9-diene-3,20-dione, 17-(acetyloxy)-11-(4-(dimethylamino)phenyl)-, (11β)- Acé­tate de (11β)-11-[4-(diméthylamino)phényl]-3,20-dioxo-19-norprégna-4,9-dién-17-yle [French] [ACD/IUPAC Name] CDB-2914 Estra-4,9-dien-3-one, 17-acetyl-17-(acetyloxy)-11-[4-(dimethylamino)phenyl]-, (11β,17α)- [ACD/​Index Name] Ulipristal acetate [USAN] [Wiki] VA2914 (10S,11S,14R,15S,17R)-14-acetyl-17-[4-(dimethylamino)phenyl]-15-methyl-5-oxotetracyclo[8.7.0.02,7.011,15]heptadeca-1,6-dien-14-yl acetate (8S,11R,13S,14S,17R)-17-acetyl-11-(4-(dimethylamino)phenyl)-13-methyl-3-oxo-2,3,6,7,8,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl acetate [(8S,11R,13S,14S,17R)-11-(4-dimethylaminophenyl)-17-ethanoyl-13-methyl-3-oxo-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-yl] ethanoate [(8S,11R,13S,14S,17R)-17-acetyl-11-(4-dimethylaminophenyl)-13-methyl-3-oxo-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-yl] acetate [126784-99-4] 17a-Acetoxy-11b-(4-dimethylaminophenyl)-19-norpregna-4,9-dien-3,20-dione 17-Ace­toxy-11-(4-N,N-dimethylaminophenyl)pregna-4,9-diene-3,20-dione 17β-acetyl-11β-[4-(dimethylamino)phenyl]-3-oxoestra-4,9-dien-17α-yl acetate 19-Norpregna-4,9-diene-3,20-dione,17-(acetyloxy)-11-[4-(dimethylamino)phenyl]-, (11b)- acetic acid [(8S,11R,13S,14S,17R)-17-acetyl-11-(4-dimethylaminophenyl)-13-methyl-3-oxo-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-yl] ester acetic acid [(8S,11R,13S,14S,17R)-17-acetyl-11-(4-dimethylaminophenyl)-3-keto-13-methyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-yl] ester acetic acid [(8S,11R,13S,14S,17R)-17-acetyl-11-[4-(dimethylamino)phenyl]-13-methyl-3-oxo-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-yl] ester CDB2914 ella [Trade name] ellaOne [Trade name] MFCD00899035 RTI 3021-012 Ulipristal (acetate) UNII-YF7V70N02B

Mol­e­c­u­lar Structure

SMILES

CC(=O)[C@]1(CC[C@@H]2[C@@]1(C[C@@H](C3=C4CCC(=O)C=C4CC[C@@H]23)c5ccc(cc5)N(C)C)C)OC(=O)C

Std­InChI

InChI=1S/C30H37NO4/c1-18(32)30(35-19(2)33)15-14-27-25-12-8-21-16-23(34)11-13-24(21)28(25)26(17-29(27,30)3)20-6-9-22(10-7-20)31(4)5/h6-7,9-10,16,25-27H,8,11-15,17H2,1-5H3/t25-,26+,27-,29-,30-/m0/s1

Std­InChIKey

OOL­LAFOL­C­SJHRE-ZHAK­MVSLSA-N

Mol­e­c­u­lar Formula

C30H37NO4

Mol­e­c­u­lar Weight

475.62

MDL Number

MFCD00899035

Prop­er­ties

Appear­ance

An off-white to yel­low crys­talline pow­der

Melt­ing Point

180.0-188.0℃

Spec­i­fi­ca­tions and Oth­er Infor­ma­tion of Our Ulipristal CAS 126784-99-4

Stan­dard

Enter­prise stan­dard

Iden­ti­fi­ca­tion Methods

HPLC/IR

Puri­ty

98%min

Spe­cif­ic Opti­cal Rotation

+175.0°~+185.0° (c=1,CH2Cl2)

Heavy Met­als

20ppm max

Loss on Drying

1.0%max

Residue on Ignition

0.1%max

Sin­gle Impu­ri­ty A

0.20%max

Unknown Indi­vid­ual Impurity

0.1%max

Total Impu­ri­ties

1.0%max

Stor­age

Under the room tem­per­a­ture and away from light

Appli­ca­tion

Com­mon­ly used as a nov­el oral emer­gency con­tra­cep­tive

Links

This prod­uct is devel­oped by our RandD com­pa­ny Cam­ing Phar­ma­ceu­ti­cal Ltd(http://​www​.cam​ing​.com/), and here is the cor­re­spond­ing linkhttp://​www​.cam​ing​.com/​u​l​i​p​r​i​s​t​a​l​-​c​a​s​-​1​2​6​7​8​4​-​9​9​-4/

Quick Inquiry

Fill out our inquiry form and one of our experts will be in touch with you short­ly (Please change screen to hor­i­zon­tal for com­plete brows­ing if you are check­ing Wat­son on your mobile phone).  andD pur­pose. It may be tox­ic or haz­ardous, and should be han­dled only by qual­i­fied indi­vid­u­als trained in lab­o­ra­to­ry pro­ce­dures. The buy­er will be respon­si­ble to warn and inform any per­son that may be in con­tact with the prod­uct of the poten­tial risks and haz­ards, as well as to ensure that pur­chase, use and dis­pos­al of the prod­uct com­ply with local laws and regulations.